Merck KGaA, Darmstadt, Germany
6 products found
Merck KGaA, Darmstadt, Germany products
SupelMIP Beta-agonists (class selective) 25 mg / 10 mL
A class selective MIP phase for the multi-residue extraction of beta-agonists in urine, tissues, and other biological fluids. SupelMIP - Beta-agonists was developed for the selective extaction of a broad range o beta-agonists such as brombuterol, clenbuterol, formoterol, isoxuprine, mapenterol, ractopamine, ritrodine, salbutamol, salmeterol, terbutaline, tulobuterol, zilpaterol and others. The SupelMIP cartridge offers excellent reproducibility for surveillance of this common class of drugs of abuse. Loading capacity is superior to immuno-affinity columns, and MS-detection is recommended for forensic validity. Detailed extraction protocols are included with the product. SupelMIP is a registered trademark of Sigma-Aldrich Co. LLC
SupelMIP Beta blockers (class selective) 25 mg / 10 mL
A class selective MIP phase for the multi-residue extraction of beta-blockers in water and biological fluids. SupelMIP - Beta-blockers was developed for the selective extaction of a broad range of beta-blockers such as altenolol, betaxolol, carazolol,metroprolol, pindolol, propanolol, sotalol and timolol, and others. The SupelMIP cartridge offers excellent reproducibility for surveillance of this common class of drugs of abuse. Loading capacity is superior to immuno-affinity columns, and MS-detection is recommended for forensic validity. Detailed extraction protocols are included with the product. The methods are highly reproducible and offer beta-blocker recoveries of > 80%. The method minimizes matrix effects and offers limits of detection of less than 5 ppt in water and less than 10 ppt for plasma and urine. SupelMIP is a registered trademark of Sigma-Aldrich Co. LLC
SupelMIP Amphetamines 25 mg / 3 mL
Developed for the class-selective extraction of Amphetamine, Methamphetamine, Phentermine, MDA, MDMA, MDEA from human urine. The method is highly reproducible and offers an average recovery greater than 80%; and limits of detection in the range of 0.8 - 12.9 pg/mL from 1 mL of urine. SupelMIP is a registered trademark of Sigma-Aldrich Co. LLC
SupelMIP Beta-agonists (class selective) 25 mg / 3 mL
A class selective MIP phase for the multi-residue extraction of beta-agonists in urine, tissues, and other biological fluids. SupelMIP - Beta-agonists was developed for the selective extaction of a broad range o beta-agonists such as brombuterol, clenbuterol, formoterol, isoxuprine, mapenterol, ractopamine, ritrodine, salbutamol, salmeterol, terbutaline, tulobuterol, zilpaterol and others. The SupelMIP cartridge offers excellent reproducibility for surveillance of this common class of drugs of abuse. Loading capacity is superior to immuno-affinity columns, and MS-detection is recommended for forensic validity. Detailed extraction protocols are included with the product. SupelMIP is a registered trademark of Sigma-Aldrich Co. LLC